Ethylcellulose nanoparticles with bimodal size distribution as precursors for the production of very small nanoparticles

Drug Development and Industrial Pharmacy

Volumn 41, Issue 7, 2015, Pages 1165-1171

  Wachsmann, Philip ^a   Lamprecht, Alf ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Emulsification solvent evaporation; indometacin; nanosphere; polymeric nanoparticle; surfactant

Indexed keywords

CETRIMIDE; DICHLOROMETHANE; DODECYL SULFATE SODIUM; ETHYL CELLULOSE; INDOMETACIN; POLIDOCANOL; POLYSORBATE 20; POLYVINYL ALCOHOL; WATER; CELLULOSE; DRUG CARRIER; NANOPARTICLE; SOLVENT; SURFACTANT;

ARTICLE; CENTRIFUGATION; DIAFILTRATION; DISPERSION; DRUG RELEASE; LIPOPHILICITY; NANOENCAPSULATION; PARTICLE SIZE; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; CHEMISTRY; MEDICINAL CHEMISTRY; PROCEDURES;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; INDOMETHACIN; NANOPARTICLES; PARTICLE SIZE; SOLVENTS; SURFACE-ACTIVE AGENTS;

EID: 84932638054     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.935393     Document Type: Article

References (27)

1. Barratt G. Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today 2000;3:163-71.
2. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009;66:2873-96.
3. Schäfer V, Briesen von H, Andreesen R, et al. Phagocytosis of nanoparticles by human immunodeficiency virus (HlV)-infected macrophages: a possibility for antiviral drug targeting. Pharm Res 1992;9:541-6.
4. Tabata Y, Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988;9:356-62.
5. Rejman J, Oberle V, Zuhorn I, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 2004;377:159-69.
6. Wang Z, Tiruppathi C, Minshall RD, Malik AB. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 2009;3:4110-16.
7. Lai SK, Hida K, Man ST, et al. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 2007;28:2876-84.
8. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006;2:8-21.
9. Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007;65:259-69.
10. Wachsmann P, Moulari B, Béduneau A, et al. Surfactant-dependence of nanoparticle treatment in murine experimental colitis. J Control Release 2013;172:62-8.
11. Abdel-Mottaleb MMA, Moulari B, Béduneau A, et al. Surface-charge-dependent nanoparticles accumulation in inflamed skin. J Pharm Sci 2012;101:4231-9.
12. Boury F, Marchais H, Benoit JP, Proust JE. Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process. Biomaterials 1997;18:125-36.
13. Gaucher G, Asahina K, Wang J, Leroux J-C. Effect of poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Biomacromolecules 2009;10:408-16.
14. Gómez-Gaete C, Tsapis N, Besnard M, et al. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm 2007;331:153-9.
15. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009;26:1025-58.
16. Abdel-Mottaleb MMA, Lamprecht A. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I. Drug Dev Ind Pharm 2011;37:178-84.
17. Limnell T, Heikkilä T, Santos HA, et al. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles. Int J Pharm 2011;416:242-51.
18. Anton N, Benoit J-P, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates - a review. J Control Release 2008;128:185-99.
19. Jafari SM, Assadpoor E, He Y, Bhandari B. Re-coalescence of emulsion droplets during high-energy emulsification. Food Hydrocolloids 2008;22:1191-202.
20. Desgouilles S, Vauthier C, Bazile D, et al. The design of nanoparticles obtained by solvent evaporation: a comprehensive study. Langmuir 2003;19:9504-10.
21. Staff RH, Schaeffel D, Turshatov A, et al. Particle formation in the emulsion-solvent evaporation process. Small 2013;9:3514-22.
22. Melzer E, Kreuter J, Daniels R. Ethylcellulose: a new type of emulsion stabilizer. Eur J Pharm Biopharm 2003;56:23-7.
23. Huynh NT, Passirani C, Saulnier P, Benoit JP. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009;379:201-9.
24. Jones M, Leroux J. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48:101-11.
25. Prabha S, Zhou W-Z, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 2002;244:105-15.
26. Gaumet M, Gurny R, Delie F. Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation. Int J Pharm 2007;342:222-30.
27. Limayem I, Charcosset C, Fessi H. Purification of nanoparticle suspensions by a concentration/diafiltration process. Sep Purif Technol 2004;38:1-9.